Clinical trials verifying the consistency of AmoyDx Essential NGS Panel (Reversible Terminator Sequencing) with local tests

ABSTRACT: Interventions: Gold Standard:Histopathological diagnosis;Index test:AmoyDx Essential NGS Panel (Reversible Terminator Sequencing) Primary outcome(s): EGFR 20 insertion mutation;consistency Study Design: Factorial

DISEASE(S): Non-small Cell Lung Cancer (nsclc), Colorectal Cancer (crc)

PROVIDER: 2699936 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR